Finance

Lists
Why is SMSPHARMA down 3.33%?
Dive Deeper
SMSPHARMA:NSE
SMS Pharmaceuticals Ltd
₹499.50
-3.33%
(-17.20) 1D
Nov 6, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for SMSPHARMA...
Open
₹514.15
High
₹519.80
Low
₹494.00
Mkt. cap
46.69B
Avg. vol.
638.46K
Volume
395.86K
Dividend
0.08%
Quarterly dividend
₹0.10
Ex-dividend date
Sep 22, 2025
P/E ratio
44.79
52-wk high
₹535.00
52-wk low
₹270.10
EPS
₹11.15
Shares outstanding
84.65M
No. of employees
2K
Open
₹514.15
High
₹519.80
Low
₹494.00
Mkt. cap
46.69B
Avg. vol.
638.46K
Volume
395.86K
Dividend
0.08%
Quarterly dividend
₹0.10
Ex-dividend date
Sep 22, 2025
P/E ratio
44.79
52-wk high
₹535.00
52-wk low
₹270.10
EPS
₹11.15
Shares outstanding
84.65M
No. of employees
2K
News stories
From web sources and news partners
About SMS Pharmaceuticals Ltd
CEO-
Employees1.62K
Founded1987
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
2.10B
2.40B
2.07B
3.17B
Cost of goods sold
1.36B
1.53B
1.32B
2.05B
Cost of revenue
1.36B
1.53B
1.32B
2.05B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
210.52M
333.60M
235.40M
272.56M
Operating expense
412.58M
546.29M
439.71M
536.27M
Total operating expenses
1.77B
2.08B
1.76B
2.59B
Operating income
336.30M
321.60M
309.60M
585.53M
Other non operating income
37.52M
-69.96M
17.44M
-
EBT including unusual items
314.43M
388.16M
279.13M
531.02M
EBT excluding unusual items
314.43M
388.16M
279.13M
531.02M
Income tax expense
79.71M
61.02M
70.04M
132.49M
Effective tax rate
25.35%
15.72%
25.09%
24.95%
Other operating expenses
101.91M
111.37M
104.40M
159.29M
Net income
234.72M
327.14M
209.09M
398.52M
Net profit margin
11.15%
13.65%
10.10%
12.55%
Earnings per share
-
-
-
-
Interest and investment income
-
6.19M
-
-
Interest expense
-62.22M
-43.16M
-55.00M
-57.36M
Net interest expenses
-62.22M
-36.98M
-55.00M
-57.36M
Depreciation and amortization charges
100.15M
101.31M
99.91M
104.42M
EBITDA
420.82M
421.00M
409.40M
687.69M
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google apps